Revance Therapeutics, Inc. financial data

Symbol
RVNC on Nasdaq
Industry
Pharmaceutical Preparations
Location
1222 Demonbreun Street, Suite 2000, Nashville, Tennessee
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 470 % +4.42%
Quick Ratio 56.2 % +123%
Debt-to-equity -742 % -142%
Return On Equity 385 %
Return On Assets -60 % -2.39%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 104M shares +24.3%
Common Stock, Shares, Outstanding 104M shares +24.3%
Entity Public Float 2.2B USD +120%
Common Stock, Value, Issued 104K USD +23.8%
Weighted Average Number of Shares Outstanding, Basic 91.9M shares +13.3%
Weighted Average Number of Shares Outstanding, Diluted 91.9M shares +13.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 240M USD +56.9%
Research and Development Expense 76.3M USD -13.4%
Operating Income (Loss) -317M USD +2.93%
Income Tax Expense (Benefit) 300K USD -57.1%
Net Income (Loss) Attributable to Parent -317M USD +9.81%
Earnings Per Share, Basic -3.67 USD/shares +21.9%
Earnings Per Share, Diluted -3.67 USD/shares +21.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 133M USD -2.98%
Cash, Cash Equivalents, and Short-term Investments 277M USD +1.17%
Accounts Receivable, after Allowance for Credit Loss, Current 29.9M USD +94.4%
Inventory, Net 50.3M USD +81%
Assets, Current 370M USD +14.4%
Property, Plant and Equipment, Net 17.5M USD +25.5%
Operating Lease, Right-of-Use Asset 70.2M USD +85.3%
Intangible Assets, Net (Excluding Goodwill) 8.73M USD -72.1%
Goodwill 0 USD -100%
Other Assets, Noncurrent 217K USD -89.5%
Assets 508M USD -7.24%
Accounts Payable, Current 5.28M USD -59.4%
Employee-related Liabilities, Current 16.9M USD +4.45%
Accrued Liabilities, Current 40.3M USD +12.4%
Contract with Customer, Liability, Current 9.78M USD +62.1%
Liabilities, Current 68.9M USD -11.6%
Contract with Customer, Liability, Noncurrent 71.4M USD -11.9%
Operating Lease, Liability, Noncurrent 38.8M USD +18.4%
Other Liabilities, Noncurrent 2.84M USD 0%
Liabilities 607M USD +5.63%
Accumulated Other Comprehensive Income (Loss), Net of Tax -25K USD +80%
Retained Earnings (Accumulated Deficit) -2.13B USD -17.5%
Stockholders' Equity Attributable to Parent -98.7M USD -270%
Liabilities and Equity 508M USD -7.24%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -65.9M USD +5.12%
Net Cash Provided by (Used in) Financing Activities 92.8M USD +2743%
Net Cash Provided by (Used in) Investing Activities -31.7M USD -133%
Common Stock, Shares Authorized 190M shares 0%
Common Stock, Shares, Issued 104M shares +24.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.82M USD -117%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 140M USD -2.89%
Interest Paid, Excluding Capitalized Interest, Operating Activities 15.1M USD +23.4%
Deferred Tax Assets, Valuation Allowance 496M USD +15.9%
Deferred Tax Assets, Gross 514M USD +17.1%
Operating Lease, Liability 45.9M USD +23.3%
Payments to Acquire Property, Plant, and Equipment 1.71M USD +96.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -317M USD +9.86%
Lessee, Operating Lease, Liability, to be Paid 63.5M USD +28.1%
Property, Plant and Equipment, Gross 37.2M USD -22.5%
Operating Lease, Liability, Current 7.13M USD +59.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11.2M USD +24.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.9M USD +24.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 17.6M USD +42.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.54M USD -50.9%
Deferred Tax Assets, Operating Loss Carryforwards 377M USD +13%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 300K USD -57.1%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 12.9M USD +32.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.02M USD +58.6%
Operating Lease, Payments 2.56M USD +22.6%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD
Current Federal Tax Expense (Benefit) 0 USD
Amortization of Intangible Assets 6.13M USD -72.3%
Depreciation, Depletion and Amortization 1.98M USD -53.9%
Deferred Tax Assets, Net of Valuation Allowance 18.6M USD +59.3%
Share-based Payment Arrangement, Expense 47M USD -3.95%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 20.1M USD +5.65%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%